Global Interventional Spine Devices Market 2017-2021
About Interventional Spine Devices
Interventional spine procedures are used to treat painful spinal conditions. Interventional treatment options are often more efficient and effective than traditional therapy for spinal (back and neck) pain. The new techniques are excellent minimally invasive alternatives to conventional surgery. Lumbar disc disease, sacroiliac joint, and degenerative lumbar facet joints pain account for nearly 70% of the cases of lower back pain. Osteoporosis is a common disease characterized by low back pain and deterioration of bone tissue, which makes the bone fragile and susceptible to fracture. Osteoporosis is also the primary cause for vertebral compression fractures (VCFs) in senior citizens. Vertebral collapse is caused by many complications, particularly osteoporosis, metastatic disease, and hemangiomas. VCFs cause impaired mobility, severe acute and chronic pain, and reduced quality of life.
Technavio’s analysts forecast the global interventional spine devices market to grow at a CAGR of 10.50% during the period 2017-2021.Covered in this report
The report covers the present scenario and the growth prospects of the global interventional spine devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various interventional procedure devices to key end-users such as hospitals, ambulatory surgical centers.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Interventional Spine Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global interventional spine devices market: Medtronic, Stryker, St. Jude Medical, DePuy Synthes, and Merit Medical.
Other Prominent Vendors in the market are: AOI Medical, Biomet, Cook Medical, Crosstrees Medical, Exactech, Globus Medical, Greatbatch Medical, Integra LifeSciences, Interventional Spine, joimax, K2M, NeuroWave Systems, Paradigm Spine, RS Medical, RTI Surgical, Stimwave, Quandary Medical, Vexim, and Zavation.
Commenting on the report, an analyst from Technavio’s team said: “One trend in market is emergence of radiofrequency-targeted vertebral augmentation. The market has been witnessing a trend toward the adoption of radiofrequency targeted vertebral augmentation, a novel percutaneous vertebral augmentation technique used to address some of the limitations of balloon kyphoplasty besides maintaining the benefits of the procedure. According to research studies, radiofrequency-targeted vertebral augmentation significantly reduces back pain severity, reduces pain medication requirements, and improves back function. Further, the remotely controlled cement delivery helps to reduce radiation exposure during vertebral augmentation procedures. As of 2014, the device has been used for the treatment of more than 15,000 spinal fractures worldwide. For instance, Merit Medical’s StabiliT System combines a targeted approach and ultra-high viscosity cement for the treatment of pathological fractures and reduce extravasation in the vertebrae.”
According to the report, one driver in market is increasing incidence of spine and bone disorders. There has been a significant rise in the incidence of spinal disorders across the world over the last decade. This is expected to fuel the market growth. The most common spinal disorders include spondylolisthesis, degenerative disc disease, herniated discs, prolapsed intervertebral disc, and spinal stenosis. Disc herniation is a result of age-related degeneration of the annulus fibrosis or trauma, lifting injuries, or straining. Approximately one-third of adults above the age of 20 shows signs of herniated disks. According to some research studies, 56% of individuals have disc bulging, and 20% to 35% of working age adults suffer from asymptomatic disc herniation. It has been estimated that lumbar disc herniation occurs 15 times more often than cervical disc herniation and is one of the major causes of lower back pain. Nearly 4%-6% of the global population is affected by this disorder, and there has been an increase in the prevalence of spondylolisthesis in gymnasts, weight lifters, and football linemen.
Further, the report states that one challenge in market is availability of alternate medication options. Opioid analgesic drugs are the major alternative treatment options available for interventional spine procedures. These drugs have been used for a long time. Despite the devices being highly effective and safer than drugs, they are still less preferred. The reason for the low preference for devices is attributed to the low cost of drugs and their non-invasive nature. Also, the introduction of innovative drug delivery techniques and improved drugs in the pipeline provides a strong competition to these devices. In addition, there is an increased demand for interventional pain therapies, such as non-narcotic treatments for chronic pain. According to research findings, the demand for epidurals increased by more than 120% between 2000 and 2008, and is still maintaining its double-digit growth. In APAC, alternative treatments like Ayurveda, yoga, and physiotherapy play a prominent role in chronic pain management. In recent years, many healthcare institutions have promoted these treatment methods as a preventive measure. Thus, these factors hinder the growth of the global interventional spine market. Some of the injections which are in use to treat spine-related disorders include epidural steroid injections, facet joints injections, and trigger point injections.
Medtronic, Stryker, St. Jude Medical, DePuy Synthes, Merit Medical, AOI Medical, Biomet, Cook Medical, Crosstrees Medical, Exactech, Globus Medical, Greatbatch Medical, Integra LifeSciences, Interventional Spine, joimax, K2M, NeuroWave Systems, Paradigm Spine, RS Medical, RTI Surgical, Stimwave, Quandary Medical, Vexim, Zavation.